Answers are grounded in this paper and cite their sources.
amplified but also HER2 expressing but not amplified breast tumors. In this article, we review the current preclinical and clinical evidence of the investigational drugs A166, ALT-P7, ARX788, DHES0815A, DS-8201a, RC48, SYD985, MEDI4276 and XMT-1522.
No takes yet. Share an insight, caveat, or question.
Rinnerthaler et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: